Correlation Between FrontView REIT, and Celltrion Pharm

Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Celltrion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Celltrion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FrontView REIT, and Celltrion Pharm, you can compare the effects of market volatilities on FrontView REIT, and Celltrion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Celltrion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Celltrion Pharm.

Diversification Opportunities for FrontView REIT, and Celltrion Pharm

-0.35

Correlation Coefficient

FrontView REIT,  Celltrion Pharm

Very good diversification

The 3 months correlation between FrontView and Celltrion is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Celltrion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celltrion Pharm and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Celltrion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celltrion Pharm has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Celltrion Pharm go up and down completely randomly.

Pair Corralation between FrontView REIT, and Celltrion Pharm

Considering the 90-day investment horizon FrontView REIT, is expected to generate 0.47 times more return on investment than Celltrion Pharm. However, FrontView REIT, is 2.12 times less risky than Celltrion Pharm. It trades about -0.02 of its potential returns per unit of risk. Celltrion Pharm is currently generating about -0.05 per unit of risk. If you would invest  1,900  in FrontView REIT, on September 26, 2024 and sell it today you would lose (44.00) from holding FrontView REIT, or give up 2.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.77%
Values	Daily Returns

FrontView REIT,  vs.  Celltrion Pharm

FrontView REIT,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FrontView REIT, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Celltrion Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celltrion Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with FrontView REIT, and Celltrion Pharm

The main advantage of trading using opposite FrontView REIT, and Celltrion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Celltrion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will offset losses from the drop in Celltrion Pharm's long position.

The idea behind FrontView REIT, and Celltrion Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.